A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
Clinical trial NCT05836779 · COMPLETED
Trial details
- NCT number
- NCT05836779
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2023-11-29
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.